Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:665-670
Published online before print February 26, 2009, doi: 10.1161/ATVBAHA.108.183319
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/5/665    most recent
ATVBAHA.108.183319v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ben-Shoshan, J.
Right arrow Articles by George, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben-Shoshan, J.
Right arrow Articles by George, J.
Related Collections
Right arrow Genetically altered mice
Right arrow Growth factors/cytokines
Right arrow Gene therapy
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:665.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

HIF-1{alpha} Overexpression and Experimental Murine Atherosclerosis

Jeremy Ben-Shoshan; Arnon Afek; Sofia Maysel-Auslender; Aya Barzelay; Ardon Rubinstein; Gad Keren; Jacob George

From the Department of Cardiology (J.B.-S., S.M.-A., A.B., G.K.), Tel Aviv Sourasky Medical Center, Israel; the Department of Pathology (A.A.), Sheba Medical Center, Tel-Hashomer, Israel; the Sackler School of Medicine (J.B.-S., A.A., S.M.-A., A.B., G.K., J.G.), Tel Aviv University, Israel; and the Lipid Metabolic Unit (A.R.), Tel Aviv Sourasky Medical Center, Israel.

Correspondence to Jacob George, MD, Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. E-mail jacobg{at}post.tau.ac.il

Background— Lymphocytes play an important role in the progression of atherosclerosis. Recently, hypoxia inducible factor-1 (HIF-1) was found to attenuate inflammation by regulating T cell activation and cytokine production. We studied the effects of overexpression of HIF-1{alpha} in ApoE knockout murine lymphocytes, on experimental atherosclerosis.

Methods and Results— ApoE–/– mice were submitted to intravenous hydrodynamic injection of empty plasmid or HIF-1{alpha}P564A (HIF-1{alpha} mutated stabilized construct). Robust expression of HIF-1{alpha} was evident in spleen cells of recipient animals. Increased expression of IL-10 as well as decreased expression of IFN-{gamma} was measured in splenocytes of HIF-1{alpha}–treated mice by RT-PCR. One week postinjection, antibody array analysis revealed a pattern consistent with a T helper 1 to T helper 2 shift. On sacrifice, assessment of aortic sinus lesions revealed a significant reduction in plaque size in HIF-1{alpha} injected mice. A reduced expression of IFN-{gamma} was evident in CD4+ spleen-derived lymphocytes and aortas of HIF-1{alpha}–injected mice.

Conclusions— HIF-1{alpha} expression in mouse lymphocytes is associated with a reduced IFN-{gamma} expression and attenuation of experimental atherosclerosis.

We used a HIF-1{alpha} plasmid delivered by hydrodynamic injection to assess the effects on cellular immunity and atherosclerotic plaque size in ApoE–/– mice. HIF-1{alpha} plasmid was expressed predominantly in CD4 cells and shifted their phenotype to the TH2 lineage concomitantly with a significant reduction in atherosclerotic plaque size.


Key Words: atherosclerosis • cytokines • immune system • hypoxia-inducible factor-1 • T lymphocytes